Smith Shellnut Wilson LLC Abb Vie Inc. Transaction History

Smith Shellnut Wilson LLC

$218 Million
Q3 2024

A detailed history of Smith Shellnut Wilson LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Smith Shellnut Wilson LLC holds 4,275 shares of ABBV stock, worth $705,332. This represents 0.39% of its overall portfolio holdings.

Number of Shares

4,275

Previous 4,287 0.28%

Holding current value

$705,332

Previous $735,000 14.83%

% of portfolio

0.39%

Previous 0.36%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $1,966 - $2,391	-12 Reduced 0.28%	4,275 $844,000
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $29,886 - $34,052	-187 Reduced 4.18%	4,287 $780,000
Q4 2023 Feb 21, 2024	SELL	$137.6 - $154.97 $5,228 - $5,888	-38 Reduced 0.84%	4,474 $693,000
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $2,650 - $3,298	-20 Reduced 0.44%	4,512 $607,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $21,299 - $25,543	-154 Reduced 3.29%	4,532 $732,000
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $18,252 - $20,934	136 Added 2.99%	4,686 $629,000
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $8,807 - $11,197	-64 Reduced 1.39%	4,550 $697,000
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $527 - $655	4 Added 0.09%	4,614 $748,000
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $13,106 - $16,583	122 Added 2.72%	4,610 $624,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $106,187 - $120,538	-998 Reduced 18.19%	4,488 $484,000
Q1 2021 Apr 06, 2021	SELL	$102.3 - $112.62 $3,580 - $3,941	-35 Reduced 0.63%	5,486 $594,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $53,123 - $71,722	660 Added 13.58%	5,521 $592,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $62,284 - $73,101	-725 Reduced 12.98%	4,861 $426,000
Q2 2020 Aug 26, 2020	SELL	$73.37 - $98.18 $4,328 - $5,792	-59 Reduced 1.05%	5,586 $548,000
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $71,079 - $107,764	-1,102 Reduced 16.33%	5,645 $430,000
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $192,514 - $240,877	2,669 Added 65.45%	6,747 $597,000
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $32,371 - $38,920	514 Added 14.42%	4,078 $309,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $1,839 - $2,351	28 Added 0.79%	3,564 $259,000
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $2,237 - $2,632	29 Added 0.83%	3,536 $285,000
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $2,257 - $2,784	-29 Reduced 0.82%	3,507 $323,000
Q3 2018 Oct 09, 2018	SELL	$88.91 - $98.84 $11,202 - $12,453	-126 Reduced 3.44%	3,536 $334,000
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $127,065 - $170,153	-1,381 Reduced 27.38%	3,662 $347,000
Q4 2017 Feb 22, 2018	BUY	$89.56 - $98.21 $11,195 - $12,276	125 Added 2.54%	5,043 $488,000
Q3 2017 Nov 17, 2017	BUY	$69.85 - $89.22 $343,522 - $438,783	4,918	4,918 $437,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Shellnut Wilson LLC , based on Form 13F filings with the SEC.

News

Stay updated on Smith Shellnut Wilson LLC with notifications on news.

Account

Smith Shellnut Wilson LLC Abb Vie Inc. Transaction History